NCT03729388View on ClinicalTrials.gov

Treatment for Opiate Addiction: Prognostic fActors of Responsiveness to Maintenance Treatment

CompletedOBSERVATIONAL
Enrollment

29

Participants

Timeline

Start Date

May 28, 2019

Primary Completion Date

May 28, 2022

Study Completion Date

May 28, 2022

Conditions
Opioid-use Disorder
Interventions
OTHER

Prognosis factor associated with good outcome.

Implementation of a systematic assessment of patient with OMT initiation. Patients included in the TOPAZE study will receive standardized clinical interviews, electrocardiograms, urinary and blood tests during a 12 months follow-up.

Trial Locations (2)

44093

Grall Bronnec, Nantes

Unknown

OPPELIA-Le triangle, Nantes

All Listed Sponsors
collaborator

CSAPA Apsyades

UNKNOWN

collaborator

OPPELIA-Le triangle

UNKNOWN

lead

Nantes University Hospital

OTHER

NCT03729388 - Treatment for Opiate Addiction: Prognostic fActors of Responsiveness to Maintenance Treatment | Biotech Hunter | Biotech Hunter